| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 03/13/2002 | EP1185641A1 Cytokine receptor mouse zcytor10 |
| 03/13/2002 | EP1185640A1 Lipocalin family protein |
| 03/13/2002 | EP1185639A1 Prostate-specific gene, pcgem1, and methods of using pcgem1 to detect, treat, and prevent prostate cancer |
| 03/13/2002 | EP1185638A1 Gene and protein sequences of phage t4 gene 35 |
| 03/13/2002 | EP1185629A1 Nucleic acid fragment and vector containing halogenase and method for the halogenation of chemical compounds |
| 03/13/2002 | EP1185627A2 Activation of dendritic cells to enhance immunity |
| 03/13/2002 | EP1185626A2 A method for the transfer of antigens to dendritic cells |
| 03/13/2002 | EP1185625A2 Neuronal cell material, use of said material as a transplant and method for producing the same |
| 03/13/2002 | EP1185624A1 Process of expressing and isolating recombinant proteins and recombinant protein products from plants, plant derived tissues or cultured plant cells |
| 03/13/2002 | EP1185622A1 Methods of making pancreatic islet cells |
| 03/13/2002 | EP1185621A2 Surface for cell culture |
| 03/13/2002 | EP1185620A2 Spheroid preparation |
| 03/13/2002 | EP1185619A2 3-dimensional in vitro models of mammaliam tissues |
| 03/13/2002 | EP1185615A2 Recombinant influenza viruses for vaccines and gene therapy |
| 03/13/2002 | EP1185559A2 Compositions and methods for cancer treatment by selectively inhibiting vegf |
| 03/13/2002 | EP1185558A1 Peptide having preptin functionality |
| 03/13/2002 | EP1185557A1 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer |
| 03/13/2002 | EP1185555A2 Compositions isolated from skin cells and methods for their use |
| 03/13/2002 | EP1185554A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof |
| 03/13/2002 | EP1185552A1 Retro-inverso peptides derived from interleukin-3 |
| 03/13/2002 | EP1185549A2 Dna encoding a human subunit of the 5-ht3 serotonin receptor |
| 03/13/2002 | EP1185547A2 Gene expression modulated in gastrointestinal inflammation |
| 03/13/2002 | EP1185545A1 Cd4-independent hiv envelope proteins as vaccines and therapeutics |
| 03/13/2002 | EP1185543A1 50 human secreted proteins |
| 03/13/2002 | EP1185306A1 Use of viral vectors and charged molecules for gene therapy |
| 03/13/2002 | EP1185299A1 Use of antibodies against cd20 for the treatment of the graft versus host disease |
| 03/13/2002 | EP1185297A2 Streptococcus pneumoniae proteins and vaccines |
| 03/13/2002 | EP1185285A1 49 human secreted proteins |
| 03/13/2002 | EP1185284A1 47 human secreted proteins |
| 03/13/2002 | EP1185258A1 Therapeutic uses for nitric oxide inhibitors |
| 03/13/2002 | EP1185211A1 Bioengineered anterior cruciate ligament |
| 03/13/2002 | EP1185169A2 USE OF TRANSGENIC MICE LACKING JunB EXPRESSION IN THE MYELOID LINEAGE |
| 03/13/2002 | EP0869805B1 Method for preparation of active substances from nacre, resulting products, useful in medicinal applications |
| 03/13/2002 | EP0721342B1 Polypeptides of the semaphorin gene family |
| 03/13/2002 | EP0672118B1 A novel b-lymphoma cell line and antigen |
| 03/13/2002 | EP0641383B1 Cellular aggregate stabilized culture and process for the development of embryos from a proembryogenic strain for use in vine regeneration techniques |
| 03/13/2002 | CN1340104A Glucose dehydrogenase fusion proteins and their utilization in expression systems |
| 03/13/2002 | CN1340103A Complex-forming proteins |
| 03/13/2002 | CN1340102A Polypeptide variants with raised heparin-binding capacity |
| 03/13/2002 | CN1340098A Astrocytes, their preparation and use thereof |
| 03/13/2002 | CN1340059A Peptides |
| 03/13/2002 | CN1339971A Application polyacrylamide gel for forming a capsule in the tissue of a mammal organism, method for cultivating cells and method for therapy of tumor and diabetes mellitus |
| 03/13/2002 | CN1339606A Technological process of continuously perfused culture of hybrid tumor and CHO cell to prepare antibody |
| 03/12/2002 | US6355778 Plant genes for sensitivity to ethylene and pathogens |
| 03/12/2002 | US6355774 Isolated p27 protein |
| 03/12/2002 | US6355483 Antisense nucleotides for use in the treatment of leukemia |
| 03/12/2002 | US6355481 Hybridoma cell line and monoclonal antibody for huntingtin protein |
| 03/12/2002 | US6355480 Nucleotide sequences which code preferential protein for use in the treatment of fertility and cell proliferation defects |
| 03/12/2002 | US6355479 Insect polypeptide for use in the treatment of autoimmune diseases, allergies and cancer |
| 03/12/2002 | US6355471 Nucleotide sequences coding transport protein; for use in the treatment of cancer, hyperplasias, restenosis, heart hypertrophy, autoimmune diseases and inflammation |
| 03/12/2002 | US6355466 Motor proteins and methods for their use |
| 03/12/2002 | US6355464 M. tuberculosis RNA polymerase alpha subunit |
| 03/12/2002 | US6355463 UDP-N-acetylenolpyruvylglucosamine reductase |
| 03/12/2002 | US6355451 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 03/12/2002 | US6355444 Detecting cancer marker in sample; obtain hybridoma sample, incubate with antibody, detect bound antibody |
| 03/12/2002 | US6355440 Detecting cell growth factors in sample; mix target sample with preferential receptors, detect binding, bound receptor indicates presence of cell growth factor in sample |
| 03/12/2002 | US6355254 Pathogenic Escherichia coli associated protein EspA |
| 03/12/2002 | US6355245 Glomerulonephritis,antibodies at low dosage |
| 03/12/2002 | US6355241 In vivo production and delivery of erythropoietin |
| 03/12/2002 | US6355239 Uses for non-autologous mesenchymal stem cells |
| 03/12/2002 | US6355237 Methods for using the obese gene and its gene product to stimulate hematopoietic development |
| 03/12/2002 | US6354242 Methods for gamete production in birds |
| 03/12/2002 | CA2357081A1 Retroviral vectors with foreign-sequence insertion between retroviral primer binding site and retroviral splice donor |
| 03/12/2002 | CA2064077C T cell receptor peptides as therapeutics for autoimmune and malignant disease |
| 03/08/2002 | CA2358061A1 Novel antibody compositions for the negative selection of specific rat leukocyte subsets |
| 03/07/2002 | WO2002018948A2 Differentially expressed epitopes and uses thereof |
| 03/07/2002 | WO2002018637A2 Diagnosis and treatment of prostate cancer |
| 03/07/2002 | WO2002018619A2 Nucleic acid constructs including a novel t-cell active promoter, and pharmaceutical compositions and methods utilizing same for regulating t-cell mediated immune response |
| 03/07/2002 | WO2002018611A2 Method for the improved production and isolation of trans-dihydroxycyclohexadiene carboxylic acids and/or derivatives thereof and a genetically modified organism suitable for the above |
| 03/07/2002 | WO2002018609A2 Methods for stable transduction of cells with viral vectors |
| 03/07/2002 | WO2002018608A2 Methods for enhancing the efficacy of cancer therapy |
| 03/07/2002 | WO2002018607A2 Transgenic plants containing molecular decoys that alter protein content therein |
| 03/07/2002 | WO2002018603A1 Isomaltulose synthase |
| 03/07/2002 | WO2002018585A2 Packaging of positive-strand rna virus replicon particles |
| 03/07/2002 | WO2002018581A2 G-protein coupled receptors |
| 03/07/2002 | WO2002018575A2 Genes expressed in the cell cycle |
| 03/07/2002 | WO2002018572A2 Membrane penetrating peptides and uses thereof |
| 03/07/2002 | WO2002018569A2 Methods for preparing human thrombopoietin polypeptides by mammalian cell cultures |
| 03/07/2002 | WO2002018560A2 Butinol i esterase |
| 03/07/2002 | WO2002018557A2 Human kinases |
| 03/07/2002 | WO2002018554A2 Isolated human drug-metabolizing proteins, nucleic acid moleculesand uses thereof |
| 03/07/2002 | WO2002018553A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 03/07/2002 | WO2002018549A1 Human embryonic stem cells derived from frozen-thawed embryo |
| 03/07/2002 | WO2002018548A2 Tyrosine hydroxylase 5' control elements and uses thereof |
| 03/07/2002 | WO2002018546A2 Plasma-derived-fibrin-based matrices and tissue |
| 03/07/2002 | WO2002018545A1 Genetic demonstration of requirement for nkx6.1, nkx2.2 and nkx6.2 in ventral neuron generation |
| 03/07/2002 | WO2002018544A2 Method and reagents for treatment of skin disorders by modulating the notch pathway |
| 03/07/2002 | WO2002018537A2 Methods of isolating genes encoding proteins of specific function and of screening for pharmaceutically active agents |
| 03/07/2002 | WO2002018536A2 Truncated bard1 protein, and its diagnostic and therapeutic uses |
| 03/07/2002 | WO2002018448A2 Percarboxylated polysaccharides, and a process for their preparation |
| 03/07/2002 | WO2002018443A2 A recombinant monoclonal antibody to phosphotyrosine-containing proteins |
| 03/07/2002 | WO2002018441A2 Electroprocessed fibrin-based matrices and tissues |
| 03/07/2002 | WO2002018440A1 Anti-angiogenic peptides |
| 03/07/2002 | WO2002018438A1 Modified proteins, isolated novel peptides, and uses thereof |
| 03/07/2002 | WO2002018422A1 Amino acid substitution mutants of interleukin 13 |
| 03/07/2002 | WO2002017980A2 Methods and compositions for tissue regeneration |
| 03/07/2002 | WO2002017949A2 Novel functions for dp214 |
| 03/07/2002 | WO2002017948A2 Control of crop pests and animal parasites through direct neuronal uptake |
| 03/07/2002 | WO2002017935A2 A method of transplantation using chemotherapy-treated allogeneic cells that enhance immune responses without graft versus host disease |
| 03/07/2002 | WO2002017858A2 Role of fosb in bone formation |